Overview

Gene Location [1]
11q21
Pathway
Chromatin remodeling/DNA methylation
Variant Type
Loss
Gene
MRE11A

MRE11A Loss is present in 0.12% of AACR GENIE cases, with chronic lymphocytic leukemia/small lymphocytic lymphoma, neuroblastoma, breast invasive ductal carcinoma, mantle cell lymphoma, and invasive breast carcinoma having the greatest prevalence [4].

Top Disease Cases with MRE11A Loss

Significance of MRE11A Loss in Diseases

Malignant Solid Tumor +

Breast Carcinoma +

Prostate Adenocarcinoma +

Ovarian Carcinoma +

Prostate Carcinoma +

Primary Peritoneal Carcinoma +

Fallopian Tube Carcinoma +

Adenocarcinoma Of The Gastroesophageal Junction +

Small Cell Lung Carcinoma +

Pancreatic Adenocarcinoma +

Gastric Carcinoma +

Non-Small Cell Lung Carcinoma +

Melanoma +

Soft Tissue Sarcoma +

Pancreatic Carcinoma +

Cervical Carcinoma +

Colorectal Carcinoma +

Endometrial Carcinoma +

Urothelial Carcinoma +

Head And Neck Carcinoma +

Non-Hodgkin Lymphoma +

Esophageal Carcinoma +

Gastric Adenocarcinoma +

Gastrointestinal Stromal Tumor +

Head And Neck Squamous Cell Carcinoma +

High Grade Ovarian Serous Adenocarcinoma +

Osteosarcoma +

Squamous Cell Lung Carcinoma +

Pancreatic Ductal Adenocarcinoma +

Mantle Cell Lymphoma +

Neuroblastoma +

Anal Carcinoma +

B-Cell Non-Hodgkin Lymphoma +

Mature T-Cell And NK-Cell Non-Hodgkin Lymphoma +

Esophageal Adenocarcinoma +

Bladder Urothelial Carcinoma +

Bladder Carcinoma +

Invasive Breast Carcinoma +

Malignant Central Nervous System Neoplasm +

Glioma +

Cancer +

Malignant Esophagogastric Neoplasm +

Malignant Uterine Neoplasm +

Lung Carcinoma +

Ampulla Of Vater Carcinoma +

Bile Duct Adenocarcinoma +

Bile Duct Carcinoma +

Biliary Tract Carcinoma +

Bronchogenic Carcinoma +

Cholangiocarcinoma +

Clear Cell Renal Cell Carcinoma +

Colorectal Adenocarcinoma +

Diffuse Large B-Cell Lymphoma +

Esophageal Squamous Cell Carcinoma +

Ewing Sarcoma +

Gallbladder Carcinoma +

Leiomyosarcoma +

Low Grade Ovarian Serous Adenocarcinoma +

Malignant Gastric Neoplasm +

Malignant Intestinal Neoplasm +

Malignant Mesothelioma +

Malignant Ovarian Epithelial Tumor +

Malignant Small Intestinal Neoplasm +

Medulloblastoma +

Multiple Myeloma +

Ovarian Clear Cell Adenocarcinoma +

Penile Carcinoma +

Rhabdomyosarcoma +

Vaginal Carcinoma +

Vulvar Carcinoma +

References

1. Hart R and Prlic A. Universal Transcript Archive Repository. Version uta_20180821. San Francisco CA: Github;2015. https://github.com/biocommons/uta

2. The UniProt Consortium. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Research. 2019;47:D506-D515.

3. Liu X, Wu C, Li C, and Boerwinkle E. dbNSFP v3.0: A one-stop database of functional predictions and annotations for human nonsynonymous and splice site SNVs. Human Mutation. 2015;37:235-241.

Liu X, Jian X, and Boerwinkle E. dbNSFP: A lightweight database of human nonsynonymous SNPs and their functional predictions. Human Mutation. 2011;32:894-899.

4. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.

5. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.